The 20 Best Metastatic Brain Tumor Doctors near Summit, NJ

Joana S. Emmolo, MD is a board certified radiation oncologist at Atlantic Health System's Overlook Medical Center and CyberKnife Center. She is a member of various tumor boards for the Carol G. Simon Cancer Center and The Gerald J. Glasser Brain Tumor Center. Dr. Emmolo has a focus on brain tumors and breast cancer, with a special interest in accelerated and minimally invasive treatment options for both disease sites. She attended the University of Medicine and Dentistry of New Jersey in Newark, NJ and served as Chief Resident at New York Methodist Hospital in Brooklyn, NY. Dr. Emmolo speaks Spanish and Italian. In her free time, Dr. Emmolo enjoys spending time with her two young boys and travelling with family. Dr. Emmolo is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. Her top areas of expertise are Radiation Induced Meningioma, Posterior Fossa Tumor, Meningioma, and Pleuropulmonary Blastoma.

Joseph P. Weiner is a board-certified and fellowship-trained radiation oncologist at Atlantic Health System's Overlook Medical Center and CyberKnife Center. He is a member of various tumor boards for the Carol G. Simon Cancer Center. He is also the co-founder of the Prostate Cancer Multidisciplinary and Second Opinion Clinic at Overlook Medical Center. Dr. Weiner is an active member of the Gerald J. Glasser Brain Tumor Center as well.Dr. Weiner is trained to treat all oncologic conditions but has advanced fellowship training and a special interest in both prostate and brain tumors. He has published over 40 peer-reviewed articles on these topics, written numerous book chapters as well as given regional and national lectures at prominent oncologic conferences. Dr. Weiner was previously involved in the training of over 15 resident physicians to become attending Radiation Oncologists, as well as mentored numerous medical students seeking experience in oncology.Dr. Weiner has professional experience with multiple radiation delivery platforms, including fellowship training with the team that invented the CyberKnife Radiosurgery unit. He also has experience with gantry-based linear accelerators such as the Varian TrueBeam. He has previously worked with Proton Beam Therapy, both high-dose rate (HDR) and low-dose rate (LDR) Brachytherapy, and the Gamma Knife Radiosurgery unit. He is able to perform three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated arc therapy (VMAT), image-guided radiation therapy (IGRT), stereotactic radiosurgery (SRS), and stereotactic body radiotherapy (SBRT). Dr. Weiner is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Radiation Induced Meningioma, Oligodendroglioma, and Prostatectomy.

Dr. Yaron Moshel is recognized not only for his distinguished expertise but also for his warmth and patience, making him one of the most skilled and forward-thinking neurosurgeons in the field. His patient-centered approach—coupled with a commitment to pioneering new treatments and technologies—continues to revolutionize comprehensive brain tumor care, providing hope when it’s needed most.One of a select few neurosurgeons specializing in the removal of deep-seated benign and malignant brain and skull base tumors, Dr. Moshel integrates advanced techniques such as computer-guided navigation, awake surgery, intraoperative brain mapping, endoscopy, and microsurgery to achieve optimal outcomes. His expertise also includes 5-ALA fluorescent imaging and both open and minimally invasive skull base approaches, further enhancing precision and safety in complex neurosurgical procedures.A leader in innovation, he is at the forefront of Laser Interstitial Thermal Therapy (LITT), Fluorescent Brain Tumor Surgery, Brachytherapy, and Intracavitary Chemotherapy, expanding the possibilities for complex tumor treatment.Dr. Moshel plays a pivotal role in Atlantic Health’s CyberKnife® TrueBeam® program, contributing to the largest Stereotactic Radiosurgery Program in the tri-state region for brain tumor treatment. Actively engaged in research, he also participates in national multicenter clinical trials, driving advancements in the field. Dr. Moshel is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Meningioma, Glioma, Glioblastoma, Awake Craniotomy, and Gamma Knife Radiosurgery.

Catherine Mazzola is a General Surgeon and a Neurosurgery provider in Hackensack, New Jersey. Dr. Mazzola is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. Her top areas of expertise are Metastatic Brain Tumor, Plagiocephaly, Hydrocephalus, Laminectomy, and Tissue Biopsy. Dr. Mazzola is currently accepting new patients.

Usman Shah is a Hematologist and an Oncologist in Summit, New Jersey. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Shah is currently accepting new patients.

Dr. Markowski has been contributing to the field of oncology since working in a cancer research lab during and after his undergraduate work at Johns Hopkins University. A desire to care for patients brought him back to his home state of New Jersey where he completed his medical school degree at Rutgers-Robert Wood Johnson Hospital in New Brunswick, NJ. He then completed internal medicine residency and subsequent hematology/oncology fellowship training at Rutgers-Robert Wood Johnson Hospital/Cancer Institute of New Jersey.Throughout his hematology and oncology career Dr Markowski has published and presented many peer-reviewed articles, abstracts, and posters on a multitude of cancer types. He has particular interest and expertise in lung cancer, gastrointestinal cancers, and breast cancer. In addition, he has extensive experience taking care of patients with both benign and malignant blood disorders. Dr. Markowski is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Thrombocytopenia, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Bone Marrow Aspiration.

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Colorectal Cancer, and Bone Marrow Aspiration.

Arthur Carminucci is a Neurosurgery provider in Berkeley Heights, New Jersey. Dr. Carminucci is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Spinal Stenosis, Congenital Cardiovascular Shunt, Normal Pressure Hydrocephalus, Laminectomy, and Microdiscectomy. Dr. Carminucci is currently accepting new patients.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Dr. Robert Aiken is a fellowship-trained neuro-oncologist and part of the Atlantic Medical Group Neuroscience Institute at Overlook Medical Center. With years of expertise in academic, clinical and administrative roles, and board-certified in neurology and neuro-oncology, he specializes in the diagnosis and management of patients with brain tumors, tumors of the spinal cord and nerves, as well as the management of paraneoplastic disorders involving the brain and nervous system. His particular interest involves translating new discoveries and developing new therapies for these disorders. A devoted researcher and educator, Dr. Aiken serves as co-director of the Gerald J. Glasser Brain Tumor Center at Atlantic Health System. He also served as director of neuro-oncology at Rutgers-Cancer Institute of New Jersey of Rutgers University. Previously, he held academic appointments in neurology, neurosurgery and oncology at Mount Sinai School of Medicine in NYC and Rush University Medical Center in Chicago. He combines clinical knowledge and extensive research in brain and spinal tumors. Dr. Aiken provides patients with a comprehensive evaluation and discusses their disease at length and the available treatments. After receiving his medical degree from Wayne State University School of Medicine in Detroit, MI, Dr. Aiken completed an internship and residency in internal medicine at Baylor College of Medicine in Houston, TX, then pursued neurologic training at the Neurological Institute of New York, Columbia-Presbyterian Medical Center. Post-residency, Dr. Aiken received his fellowship training at Memorial Sloan-Kettering Cancer Center. He is the author of many professional research journal articles. Dr. Aiken has been named among America’s Top Doctors and America’s Top Doctors for Cancer from Castle Connolly, Best Doctors in Philadelphia, New York and Chicago and by Inside Jersey magazine. He is on many best doctors lists. Dr. Aiken is part of Atlantic Medical Group and a participating provider of the Atlantic Accountable Care Organization. Dr. Aiken is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliosarcoma.

Enrique Feoli is a Neurologist in Summit, New Jersey. Dr. Feoli is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Seizures, Landau-Kleffner Syndrome, Memory Loss, and Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE). Dr. Feoli is currently accepting new patients.

Eric Geller is a Neurologist in Livingston, New Jersey. Dr. Geller is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Seizures, Partial Familial Epilepsy, Epilepsy, Deep Brain Stimulation, and Gastrostomy. Dr. Geller is currently accepting new patients.

Andy Rodriguez is a Neurologist in Livingston, New Jersey. Dr. Rodriguez has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Seizures, Memory Loss, Landau-Kleffner Syndrome, Autosomal Dominant Partial Epilepsy with Auditory Features, and Gastrostomy. Dr. Rodriguez is currently accepting new patients.

Luigi Bassani is a General Surgeon in Livingston, New Jersey. Dr. Bassani is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Brain Herniation, Chiari Malformation Type 1, Chiari Malformation, and Hydrocephalus. Dr. Bassani is currently accepting new patients.

Dr. James K. Liu is the Director of Skull Base Institute of New Jersey, with the Neurosurgeons of New Jersey, and the Department of Neurosurgery at Cooperman Barnabas Medical Center, RWJ Barnabas Health. Dr. Liu is an international leader in skull base surgery, advancing treatments for complex tumors in the brain, skull base, and spinal cord, including pituitary tumors, acoustic neuromas, meningiomas, chordomas, and paragangliomas. His expertise extends to cerebrovascular microsurgery, addressing conditions like brain aneurysms, arteriovenous malformations, cavernous malformations, moyamoya, and neurovascular compression syndromes (trigeminal neuralgia, hemifacial spasm). Dr. Liu utilizes advanced technology and innovative cutting-edge techniques, including minimally invasive endoscopic endonasal surgery (“EEA”), keyhole microneurosurgery, and awake craniotomy with brain mapping, to treat complex tumors and neurovascular diseases. Dr. Liu is an international expert and highly sought-after Visiting Professor, with over 500 invited lectures worldwide. As the creator of the “The Art of Brain Surgery: Masterclass” Youtube series and a prolific author of over 300 published journal articles and 30 textbook chapters, Dr. Liu is dedicated to advancing the field of neurosurgery through education and research. Dr. Liu is actively involved in teaching hands-on cadaver dissection courses in skull base surgery and has delivered lectures worldwide.He is a member of the World Academy of Neurological Surgery, Society of University Neurosurgeons, and founding member of the Yaşargil Microneurosurgery Academy and currently holds the position of Secretary-Treasurer of the International Meningioma Society and is on the Medical Advisory Board for the Acoustic Neuroma Association of New Jersey. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Glomus Tympanum Tumor, Glomus Jugulare Tumor, Pituitary Tumor, Awake Craniotomy, and Extracranial-Intracranial Bypass Surgery.

David Poulad is a Neurosurgery provider in Union, New Jersey. Dr. Poulad is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Subependymoma, Cervical Myelopathy, Spinal Stenosis, Laminectomy, and Microdiscectomy. Dr. Poulad is currently accepting new patients.

Anil Nair is a Neurosurgery provider in Union, New Jersey. Dr. Nair is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Stroke, Subarachnoid Hemorrhage, Subdural Hematoma, Gastrostomy, and Transmyocardial Revascularization. Dr. Nair is currently accepting new patients.

Karleung Siu is a Hematologist and an Oncologist in Florham Park, New Jersey. Dr. Siu is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Anemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Siu is currently accepting new patients.

Dr. Nicholas Metrus is a board-certified, fellowship-trained neurologist/neuro-oncologist with Atlantic Medical Group Neuroscience Associates and the Gerald J. Glasser Brain Tumor Center at Atlantic Health System. He is a specialist in the diagnosis and treatment of patients with brain tumors and conditions of the central nervous system. Dr. Metrus is part of a medical team that works together to provide exceptional personalized care for every patient using a multidisciplinary and comprehensive approach. His commitment to individualized care includes designing and overseeing each patient’s treatment plan, which can include any combination of chemotherapy, target therapy, and immunotherapy.Throughout his medical education, Dr. Metrus devoted his time to cutting-edge research and publishing his work on topics such as paraneoplastic disorders, tumefactive multiple sclerosis, and clinical trial enrollment, to name a few. He has also published book chapters on ependymomas and advances in clinical trial design for brain tumors. He pursed his fellowship training in neuro-oncology at MD Anderson Cancer Center, where he was the 2018 recipient of a research grant, the William James Miller Endowed Fellowship Award, for his work in Guillain Barre Syndrome following stem cell transplants, and again in 2019 for his description of unique presentations of cancer in the brain.His research on hypermutator gliomas has been presented at national and international medical conferences. Dr. Metrus earned his medical degree from the American University of the Caribbean and went on to complete his residency in neurology at the University of Texas Medical Branch. Dr. Metrus is a participating provider of the Atlantic Accountable Care Organization. Dr. Metrus is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Meningioma, Glioma, Oligodendroglioma, and Astrocytoma.

Dr. Frisoli is a highly skilled neurosurgeon whose expertise in brain tumor and skull base surgery makes him an invaluable asset to the Gerald J. Glasser Brain Tumor Center. With extensive fellowship training, he brings a wealth of specialized insight to the treatment of complex brain and skull base tumors, ensuring patients receive the most advanced, personalized care.Beyond his surgical precision, Dr. Frisoli is known for his unparalleled compassion, providing every patient with thoughtful, individualized care. His forward-thinking, meticulous approach allows him to deliver the safest, most effective treatments for even the most challenging brain and spine conditions.A leader in innovation, Dr. Frisoli is actively advancing the fields of minimally invasive spine surgery and state-of-the-art artificial disc replacement technology, continually pushing the boundaries of neurosurgical excellence. Dr. Frisoli is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Pica, Posterior Fossa Tumor, Dysembryoplastic Neuroepithelial Tumors (DNET), Awake Craniotomy, and Thrombectomy.